Overall rank by patents
#27,302
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Secretary holds 10 US patents across 4 technology areas, rank #27,302 of 50,000 tracked assignees.
Secretary, Department OF Biotechnology has been granted 10 US utility patents between 2015 and 2023, placing Secretary, Department OF Biotechnology at rank #27,302 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Secretary, Department OF Biotechnology is one of the more focused assignees in the PatentsView dataset. By volume, Secretary sits between SCF Pharma Inc. (10 patents, rank #27,298) and Sen-jam Pharmaceutical Inc. (10 patents, rank #27,306) - the closest US assignees by grant volume. The composite Innovation Score of 25.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 4 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Secretary, Department OF Biotechnology's 10.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Secretary, Department OF Biotechnology against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SCF PHARMA INC.
10 patents
SCHURTER AG
10 patents
SCRIBE OPCO, INC.
10 patents
SEAONE HOLDINGS, LLC
10 patents
SELAS HEAT TECHNOLOGY COMPANY LLC
10 patents
SEMIQ INCORPORATED
10 patents
SEMROCK, INC.
10 patents
SEN-JAM PHARMACEUTICAL INC.
10 patents
SECRETARY, DEPARTMENT OF BIOTECHNOLOGY
10 patents
What this shows Secretary holds 10 patents at rank #27,302, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,302 in granted patent volume.
Other assignees with the most granted patents in Secretary's primary technology class.
Secretary's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
26 Top 82% higher than 18% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2019 | 2 | 20.0% |
| 2020 | 3 | 30.0% |
| 2022 | 1 | 10.0% |
| 2023 | 2 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#27,302
Across all tracked assignees
25.8 out of 100
How to use this portfolio
Secretary's 10 grants land it in the top 82% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.